Trending

GENSCO® TRENDING

Antimicrobial Properties of LiDORx® August 8, 2017 Clinical, Featured, Research - Antimicrobial Properties of LiDORx® Research Report[1] Assessment of LiDORx® Antimicrobial Activity Against Common Skin Pathogens By: Robert L. Wilbur, PharmD, CPh; David A. Andry, OTR/L Background LiDORx® gel, 3% Lidocaine HCl, combined with Gensco Pharma’s patented transdermal delivery technology, is an amide type anesthetic that has demonstrated significantly faster onset more...

LOOKING TO THE FUTURE

A single dose topical colchinium for acute gout flares.

LidoDose Logo

A single dose topical anesthetic for injections and vaccines.

Click here for all trending items